Free Trial

Concentrix Corporation (CNXC) - What Are Investment Firms Thinking About This Stock?

Concentrix logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts rate Concentrix “Hold” on average: Of six brokerages, three recommend buying, two advise holding and one rates it a sell. The average 12-month price target is $33.50, with targets ranging from Bank of America’s $29 to Canaccord Genuity’s $45.
  • Institutional ownership is substantial: Hedge funds and other institutions own 90.34% of the company, with BlackRock, Dimensional Fund Advisors, Pzena Investment Management and others recently building or initiating positions.
  • Quarterly results beat earnings expectations but showed softer revenue: Concentrix reported adjusted EPS of $2.92 versus the $2.71 consensus, while revenue fell 1.2% year over year to $2.45 billion. The company also raised its quarterly dividend to $0.37 per share, implying a 4.8% annualized yield.
  • Five stocks to consider instead of Concentrix.

Concentrix Corporation (NASDAQ:CNXC - Get Free Report) has earned an average rating of "Hold" from the six brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $33.50.

Several analysts have recently commented on the stock. Canaccord Genuity Group restated a "buy" rating and issued a $45.00 target price on shares of Concentrix in a research note on Wednesday, September 30th. Bank of America reiterated a "neutral" rating and set a $29.00 price target on shares of Concentrix in a research note on Thursday, October 1st. Zacks Research raised shares of Concentrix from a "strong sell" rating to a "hold" rating in a report on Monday, August 31st. Finally, Weiss Ratings reissued a "sell (d)" rating on shares of Concentrix in a report on Thursday, October 22nd.

View Our Latest Stock Report on Concentrix

Institutional Investors Weigh In On Concentrix

A number of hedge funds and other institutional investors have recently bought and sold shares of CNXC. BlackRock Inc. acquired a new position in shares of Concentrix during the 2nd quarter worth $149,639,000. Dimensional Fund Advisors LP grew its position in Concentrix by 18.5% during the first quarter. Dimensional Fund Advisors LP now owns 2,951,378 shares of the company's stock worth $80,746,000 after buying an additional 460,108 shares during the period. Pzena Investment Management LLC acquired a new position in Concentrix during the second quarter worth about $76,488,000. Groupe Bruxelles Lambert acquired a new position in Concentrix during the second quarter worth about $68,000,000. Finally, Kopernik Global Investors LLC purchased a new position in Concentrix in the first quarter valued at about $44,523,000. Institutional investors and hedge funds own 90.34% of the company's stock.

Concentrix Trading Up 2.5%

NASDAQ:CNXC opened at $30.89 on Tuesday. The firm has a market cap of $1.89 billion, a P/E ratio of -0.79, a PEG ratio of 0.58 and a beta of 0.52. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 2.22. The stock's 50 day simple moving average is $28.57 and its 200-day simple moving average is $28.63. Concentrix has a 12-month low of $19.12 and a 12-month high of $44.78.

Concentrix (NASDAQ:CNXC - Get Free Report) last issued its quarterly earnings results on Tuesday, September 29th. The company reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.71 by $0.21. Concentrix had a positive return on equity of 25.00% and a negative net margin of 23.99%. The firm had revenue of $2.45 billion during the quarter, compared to the consensus estimate of $2.48 billion. During the same period last year, the company earned $2.78 earnings per share. The company's revenue for the quarter was down 1.2% on a year-over-year basis. Concentrix has set its FY 2026 guidance at 10.970-11.090 EPS and its Q4 2026 guidance at 2.860-2.980 EPS. Equities analysts anticipate that Concentrix will post 9.77 EPS for the current year.

Concentrix Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 3rd. Stockholders of record on Friday, October 23rd will be paid a dividend of $0.37 per share. This is a positive change from Concentrix's previous quarterly dividend of $0.36. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.8%. Concentrix's dividend payout ratio (DPR) is currently -3.80%.

About Concentrix

(Get Free Report)

Concentrix Corporation NASDAQ: CNXC is a global technology and services company that helps businesses improve customer engagement and operational performance. Its offerings include customer experience management, digital operations, business process services, consulting, analytics, artificial intelligence, automation, and technology solutions.

The company supports customer care, technical support, sales, marketing, trust and safety, and back-office functions. Concentrix serves organizations across industries such as technology and electronics, retail, banking and financial services, healthcare, travel and transportation, communications and media, and automotive.

Concentrix operates across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Further Reading

Analyst Recommendations for Concentrix (NASDAQ:CNXC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines